Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

MeDe: Carpal tunnel release with added lacertus release vs carpal tunnel release alone

Official title: MeDe Study: A Randomized Controlled Trial Comparing Median Nerve Decompression at the Carpal Tunnel Alone Versus Median Nerve Decompression at Both the Carpal Tunnel and Lacertus Fibrosis in Adults With Carpal Tunnel Syndrome

Run by Maasstad Hospital · NCT07594821 · Data updated 2026-11-12

In adults with carpal tunnel syndrome, this trial tests whether adding a lacertus fibrosus release to the standard carpal tunnel release helps reduce symptoms and improve hand function.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment110 (estimated)
SponsorMaasstad Hospital
Academic / other
Locations2 sites (Rotterdam, South Holland and 1 other locations)
StatusRecruiting
StartedMay 6, 2026
Main results expectedFebruary 2028
Study endsFebruary 2028
Registry record updatedJune 26, 2026
Trial IDNCT07594821 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with CTS confirmed by EMG or nerve ultrasound who are planning surgical treatment and meet eligibility criteria.

Probably not a fit

Patients without proximal nerve compression or who respond well to standard carpal tunnel release alone may see no additional benefit from the extended procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two surgical approaches for CTS: releasing only the carpal tunnel versus releasing both the carpal tunnel and the lacertus fibrosus. It targets adults with CTS confirmed by EMG or nerve ultrasound. Outcomes will come from patient-reported symptoms and function after surgery, aiming to see if the extended release provides additional relief for those whose proximal nerve compression may contribute to ongoing symptoms. The study addresses a gap where proximal compression is hard to detect with standard tests, potentially guiding more comprehensive surgical care. Participating centers are Maasstad Hospital in Rotterdam and Spijkenise Medisch Centrum, with adults 18+ who choose surgical treatment and meet eligibility criteria.

Why it matters

Potential benefit: If successful, patients may experience greater symptom relief and fewer residual problems after CTS surgery by addressing proximal nerve compression.

How similar studies have gone: Previous CTS surgeries show substantial residual symptoms in some patients, and there is emerging interest in addressing proximal compression; whether this exact approach will improve outcomes is being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients being at least 18 years or older
* CTS confirmed by EMG or nerve ultrasound
* Patient opts for surgical treatment

Exclusion Criteria:

* Previous surgical decompression of the median nerve at the ipsilateral wrist or forearm
* Severe thenar atrophy: Examination of the thenar is based on clinical observation. The presence of thenar muscle atrophy is scored as none, mild, or severe.
* Simultaneous nerve decompression in the ipsilateral arm (e.g. cubital tunnel, Guyon and radial nerve release.
* Neurological disorders affecting peripheral nerves (e.g. spinal cord compression or injury, muscular dystrophy, dystonia, ALS)
* Malunion of the distal radius
* Impaired hand function
* Pregnancy
* Inability to complete study forms due to insufficient comprehension of the Dutch language

Where it's running

  • Maasstad Ziekenhuis
    Rotterdam, South Holland, Netherlands
    Recruiting
  • Spijkenise Medisch Centrum
    Rotterdam, South Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.